bcl-2 protein expression correlates with recurrence and survival in early stage head and neck cancer treated by radiotherapy.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (28)
Apoptosis in the Pathogenesis and Treatment of Disease
1995 • 6,610 citations
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
1988 • 3,194 citations
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
1993 • 2,969 citations
Bcl-2 and the regulation of programmed cell death
1994 • 2,346 citations
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
1991 • 1,301 citations
bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
1991 • 1,223 citations
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
1991 • 1,090 citations
Bcl-2 initiates a new category of oncogenes: regulators of cell death
1992 • 1,078 citations
Estimates of the worldwide frequency of sixteen major cancers in 1980
1988 • 1,073 citations
Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.
1992 • 1,063 citations
Cancer statistics, 1993
1993 • 983 citations
bcl-2 Protein in Non-Small-Cell Lung Carcinoma
1993 • 684 citations
DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2
1994 • 671 citations
Molecular Cloning of the Chromosomal Breakpoint of B-Cell Lymphomas and Leukemias with the t(11;14) Chromosome Translocation
1984 • 671 citations
The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer Patients
1994 • 461 citations
Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
1994 • 280 citations
Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
1993 • 262 citations
Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin.
1991 • 222 citations
Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer
1995 • 201 citations
Bcl‐2 proto‐oncogene expression in epstein‐barr‐virus‐associated nasopharyngeal carcinoma
1993 • 198 citations
Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients.
1986 • 176 citations
Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy
1988 • 169 citations
BCL-2 expression in human colorectal adenomas and carcinomas.
1994 • 168 citations
Local control and patient survival
1992 • 145 citations
Risks of Head and Neck Surgery in Previously Irradiated Patients
1973 • 131 citations
Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.
1995 • 79 citations
Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
1995 • 46 citations
Are postoperative complications more frequent and more serious after irradiation for laryngeal and hypopharyngeal cancer?
1984 • 16 citations